TBPH icon

Theravance Biopharma
TBPH

Overview Fund Trends Analyst Outlook Journalist POV

94 hedge funds and large institutions have $722M invested in Theravance Biopharma in 2014 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$131K
Puts
$135K
Net Calls
Net Calls Change

Top Buyers

1
+$193M
2
+$66.5M
3
+$66M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$43.7M
5
O
OppenheimerFunds
New York
+$34.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$193M
2
$66.5M
3
$66M
4
$43.7M
5
$34.6M
6
$26.1M
7
$25.6M
8
$20.9M
9
$19M
10
$17M
11
$15.7M
12
$14.9M
13
$14.6M
14
$14.5M
15
$14M
16
$13.8M
17
$9.59M
18
$8.46M
19
$7.04M
20
$6.39M
21
$5.61M
22
$4.85M
23
$4.27M
24
$4.14M
25
$4M
1
2 3 4